Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 287

Results For "LA"

8967 News Found

Manjushree Technopack set to acquire Classy Kontainers
Packaging | August 17, 2021

Manjushree Technopack set to acquire Classy Kontainers

MTL, with over 40 years of experience in packaging, caters to the requirements of the FMCG, F&B, homecare, personal care, agrochemicals, pharmaceutical, and liquor industries


Aster DM Heathcare plans India expansion
Healthcare | August 16, 2021

Aster DM Heathcare plans India expansion

Investment of Rs 235 crores to add 411 beds in the next 18 months


Zydus Cadila receives final approval for Mesalamine extended-release capsules
Drug Approval | August 16, 2021

Zydus Cadila receives final approval for Mesalamine extended-release capsules

The group has a total of 320 ANDA approvals


Apollo Hospitals inks MoU with Group of Hospitals for liver transplant
Healthcare | August 14, 2021

Apollo Hospitals inks MoU with Group of Hospitals for liver transplant

The MoU was signed on World Organ Donation Day which falls on August 13


Unichem Labs receive ANDA approval for Metformin Hydrochloride
News | August 13, 2021

Unichem Labs receive ANDA approval for Metformin Hydrochloride

It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus


Labcorp, a leader in women’s heath solutions acquires Ovia Health
Digitisation | August 13, 2021

Labcorp, a leader in women’s heath solutions acquires Ovia Health

The transaction improves patient experience, patient outcomes and aims to reduce health care costs


Ind-Swift Laboratories PAT at Rs 18.80 cr for Q1FY22
News | August 13, 2021

Ind-Swift Laboratories PAT at Rs 18.80 cr for Q1FY22

EPS stood at Rs 3.18


Mangalam Drugs signs tech transfer agreement with Nigerian pharma company
News | August 12, 2021

Mangalam Drugs signs tech transfer agreement with Nigerian pharma company

Anti-malaria API facility will be operational in 15-18 months


Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee
Drug Approval | August 12, 2021

Biocon Biologics and Viatris receive approval for first interchangeable biosimilar Semglee

The company is eligible for 12 months exclusivity from launch


Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%
Drug Approval | August 12, 2021

Cipla receives USFDA approval for Difluprednate Ophthalmic Emulsion 0.05%

It’s an AB-rated generic therapeutic version of Durezol